SCHEMBL25166304

SCHEMBL25166304

Cc1cc(NC2CCCC2)nc(Cl)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN2 Q9H2S1 1/20 0.54
KCNN3 Q9UGI6 1/20 0.54
LMNA P02545 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
HTT P42858 1/20 0.51
NUDT1 P36639 1/20 0.47
KDM4E B2RXH2 2/20 0.47
PDE4A P27815 1/20 0.46
ALDH1A1 P00352 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
DNM2 P50570 1/20 0.45
RAB9A P51151 1/20 0.44
ABL1 P00519 1/20 0.43
RIN1 Q13671 1/20 0.43
CDC7 O00311 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29770768 1.00 KCNN2 (0.54) KCNN2KCNN3LMNAMEN1KMT2A
SCHEMBL6128335 0.98 KCNN2 (0.56) KCNN2KCNN3LMNAMEN1KMT2A
SCHEMBL25166077 0.97 KCNN2 (0.50) KCNN2KCNN3LMNAMEN1KMT2A
SCHEMBL12574434 0.85 MAPK1 (0.47) KCNN2KCNN3LMNAMEN1KMT2A
SCHEMBL12526925 0.85 HRH3 (0.43) KCNN2KCNN3LMNAMEN1KMT2A
SCHEMBL30329714 0.85 HRH3 (0.43) KCNN2KCNN3LMNAMEN1KMT2A
Hydrochloric Acid SCHEMBL1748747 0.84 HRH3 (0.42) KCNN2KCNN3LMNAMEN1KMT2A
SCHEMBL19686518 0.83 IDH1 (0.45) KCNN2KCNN3LMNAMEN1KMT2A
SCHEMBL9084790 0.82 KMT2A (0.57) KCNN2KCNN3LMNAMEN1KMT2A
SCHEMBL6050581 0.81 KMT2A (0.60) KCNN2KCNN3LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174662-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES CILAG AG (CH) 2024-05-30 US disclosed
EP-4284802-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES Janssen Biotech, Inc. (US) 2023-12-06 EP disclosed
WO-2023064586-A1 NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF TANGO THERAPEUTICS, INC. (US) 2023-04-20 WO disclosed
WO-2022165530-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES JANSSEN BIOTECH, INC. (US) 2022-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174662-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES SIK2, SIK1, SGK2 KCNN2 359/4885KCNN3 421/4885LMNA 2773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.